Screening three new prescriptions for a clinical problem
PEBC OSCE practice station

Prescription review · 2 min to read · 7 min to perform

Open this station

A written station. Free to try, no sign-up.

The task

You are a pharmacist in a community pharmacy. Three new prescriptions are waiting for your clinical check before they are filled. The details of each prescription and the patient information are in the patient folder. Decide whether each should be dispensed as written. If any prescription has a clinical problem that needs action, say which one, explain the problem, and state what you would do. Write your answer in the response sheet. The assessor will not take part.

Answer for this station

What a strong answer does

  • Safety: Identifies prescription 1, tadalafil with isosorbide mononitrate, as the one with a clinical problem requiring action.
  • Safety: States the harm: PDE5 inhibitor plus nitrate causes severe hypotension, and the combination is contraindicated.
  • Does not dispense prescription 1 as written and says the prescriber must be contacted before any supply.
  • Considers the patient's needs: asks the prescriber about alternatives for his erectile dysfunction and angina, and tells the patient not to use any similar product.
  • Judges prescription 2 appropriate with a reason, noting the regimen and duration, and plans counselling.
  • Judges prescription 3 appropriate with a reason, noting that the combination with amlodipine is acceptable at this dose, and plans counselling.
  • Gives safety-net advice for the patient on the nitrate, including seeking emergency care for chest pain.
  • Documents the intervention and the prescriber's response.

Model answer

I check each prescription against its patient profile. Prescription 1 is tadalafil 5 mg daily for Mr Cardinal, aged 63. His profile shows isosorbide mononitrate extended-release 60 mg daily for angina. Phosphodiesterase type 5 inhibitors such as tadalafil can cause severe and potentially life-threatening hypotension when combined with nitrates, and the combination is contraindicated, so I will not dispense it as written. I call the prescriber, explain the problem and ask about another way to manage his erectile dysfunction while his angina is treated. I counsel Mr Cardinal not to take tadalafil, sildenafil or any similar product, and to seek emergency care by calling 911 if he has chest pain after taking one. Prescription 2 is penicillin V potassium 300 mg four times daily for ten days for Ms Eze, aged 41, with confirmed strep throat. She has no allergy or interacting medicines and the regimen is appropriate. I can dispense it and counsel her to finish the course, take it spaced through the day and report any rash or swelling. Prescription 3 is atorvastatin 20 mg daily for Mr Fontaine, aged 55, with high LDL cholesterol. He takes amlodipine, which has no significant interaction at this dose, and his liver tests are normal. I can dispense it and counsel him to take it daily, report unexplained muscle pain and avoid large amounts of grapefruit juice. I document the intervention on prescription 1 and the outcome of the call.

What this station tests

  • Screen every prescription against the whole profile, including cardiac medicines.
  • PDE5 inhibitors and nitrates are a classic contraindicated pair.
  • Hold the problem prescription, call the prescriber and propose a next step.
  • Do not leave the patient unsupported: advise on similar products and emergency signs.
  • Judge the other prescriptions explicitly and say why they are appropriate.

Sources for the clinical content

An original practice scenario with invented patients. Not an exam question. Written from the guidance above and reviewed before release: how we write and check stations.

Practise next

About the PEBC OSCE →